Shrank WH - Search Results

1

Osteoporosis telephonic intervention to improve medication regimen adherence: a large, pragmatic, randomized controlled trial.

Solomon DH, Iversen MD, Avorn J, Gleeson T, Brookhart MA, Patrick AR, Rekedal L, Shrank WH, Lii J, Losina E, Katz JN. Solomon DH, et al. Among authors: shrank wh. Arch Intern Med. 2012 Mar 26;172(6):477-83. doi: 10.1001/archinternmed.2011.1977. Epub 2012 Feb 27. Arch Intern Med. 2012. PMID: 22371876 Free PMC article. Clinical Trial.

2

The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions.

Shrank WH, Hoang T, Ettner SL, Glassman PA, Nair K, DeLapp D, Dirstine J, Avorn J, Asch SM. Shrank WH, et al. Arch Intern Med. 2006 Feb 13;166(3):332-7. doi: 10.1001/archinte.166.3.332. Arch Intern Med. 2006. PMID: 16476874

3

Highlights and a hidden hazard--the FDA's new labeling regulations.

Avorn J, Shrank W. Avorn J, et al. N Engl J Med. 2006 Jun 8;354(23):2409-11. doi: 10.1056/NEJMp068119. N Engl J Med. 2006. PMID: 16760439 No abstract available.

4

Should patients receive secondary prevention medications for free after a myocardial infarction? An economic analysis.

Choudhry NK, Avorn J, Antman EM, Schneeweiss S, Shrank WH. Choudhry NK, et al. Among authors: shrank wh. Health Aff (Millwood). 2007 Jan-Feb;26(1):186-94. doi: 10.1377/hlthaff.26.1.186. Health Aff (Millwood). 2007. PMID: 17211028

5

Effect of content and format of prescription drug labels on readability, understanding, and medication use: a systematic review.

Shrank W, Avorn J, Rolon C, Shekelle P. Shrank W, et al. Ann Pharmacother. 2007 May;41(5):783-801. doi: 10.1345/aph.1H582. Epub 2007 Apr 10. Ann Pharmacother. 2007. PMID: 17426075 Review.

6

Physician follow-up and provider continuity are associated with long-term medication adherence: a study of the dynamics of statin use.

Brookhart MA, Patrick AR, Schneeweiss S, Avorn J, Dormuth C, Shrank W, van Wijk BL, Cadarette SM, Canning CF, Solomon DH. Brookhart MA, et al. Arch Intern Med. 2007 Apr 23;167(8):847-52. doi: 10.1001/archinte.167.8.847. Arch Intern Med. 2007. PMID: 17452550

7

Educating patients about their medications: the potential and limitations of written drug information.

Shrank WH, Avorn J. Shrank WH, et al. Health Aff (Millwood). 2007 May-Jun;26(3):731-40. doi: 10.1377/hlthaff.26.3.731. Health Aff (Millwood). 2007. PMID: 17485751

8

Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect.

Brookhart MA, Patrick AR, Dormuth C, Avorn J, Shrank W, Cadarette SM, Solomon DH. Brookhart MA, et al. Am J Epidemiol. 2007 Aug 1;166(3):348-54. doi: 10.1093/aje/kwm070. Epub 2007 May 15. Am J Epidemiol. 2007. PMID: 17504779

9

Patient, physician, pharmacy, and pharmacy benefit design factors related to generic medication use.

Shrank WH, Stedman M, Ettner SL, DeLapp D, Dirstine J, Brookhart MA, Fischer MA, Avorn J, Asch SM. Shrank WH, et al. J Gen Intern Med. 2007 Sep;22(9):1298-304. doi: 10.1007/s11606-007-0284-3. Epub 2007 Jul 24. J Gen Intern Med. 2007. PMID: 17647066 Free PMC article.

10

The variability and quality of medication container labels.

Shrank WH, Agnew-Blais J, Choudhry NK, Wolf MS, Kesselheim AS, Avorn J, Shekelle P. Shrank WH, et al. Arch Intern Med. 2007 Sep 10;167(16):1760-5. doi: 10.1001/archinte.167.16.1760. Arch Intern Med. 2007. PMID: 17846395

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

278 results

Search Page